ANDA 84915, held by Nexgen Pharma Inc. Folic Acid.
As of Nov 15, 2026, ANDA 84915 (Folic Acid), held by Nexgen Pharma Inc, was first approved by FDA on Feb 4, 1976, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Feb 4, 1976 | Original application | Approved |
| Product | Active ingredient | Marketing |
|---|---|---|
| Folic Acid1MG ยท tablet;oral | Folic Acid | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
